SCHEMBL30416876

SCHEMBL30416876

CC(=O)Nc1ccc(F)c2c1CCC2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
CA1 P00915 2/20 0.43
CA2 P00918 2/20 0.43
CA9 Q16790 2/20 0.43
ALDH1A1 P00352 2/20 0.42
HPGD P15428 1/20 0.42
NPC1 O15118 4/20 0.40
RAB9A P51151 4/20 0.40
POLB P06746 2/20 0.40
MAPT P10636 1/20 0.40
KDM4E B2RXH2 2/20 0.39
HSD17B10 Q99714 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.38
ADRA2A P08913 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.37
ALOX15 P16050 1/20 0.37
HTT P42858 1/20 0.37
MCL1 Q07820 1/20 0.37
TDP1 Q9NUW8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25237122 1.00 HDAC1 (0.44) HDAC1HDAC6CA1CA2CA9
SCHEMBL9797400 0.83 ALDH1A1 (0.48) CA1CA2CA9ALDH1A1HPGD
SCHEMBL7658479 0.83 BRD4 (0.41) HDAC1HDAC6CA1CA2CA9
SCHEMBL13732107 0.82 ALDH1A1 (0.48) CA1CA2CA9ALDH1A1HPGD
SCHEMBL30684095 0.82 USP2 (0.45) ALDH1A1NPC1RAB9APOLBMAPT
SCHEMBL20754660 0.82 USP2 (0.45) ALDH1A1NPC1RAB9APOLBMAPT
SCHEMBL11561836 0.81 POLB (0.49) HDAC1CA1CA2CA9ALDH1A1
SCHEMBL13731847 0.79 NISCH (0.47) CA1CA2CA9ALDH1A1HPGD
SCHEMBL30567319 0.79 RXFP1 (0.51) HDAC1HDAC6CA1CA2CA9
SCHEMBL25906721 0.79 CA1 (0.43) CA1CA2CA9ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250109126-A1 DIHYDRO-OXAZOL DERIVATIVE COMPOUNDS AC IMMUNE SA (CH) 2025-04-03 US disclosed
EP-4452972-A1 DIHYDRO-OXAZOL DERIVATIVE COMPOUNDS AC Immune SA (CH) 2024-10-30 EP disclosed
CN-118541366-A Dihydrooxazole derivative compound AC免疫有限公司 2024-08-23 CN disclosed
WO-2023118521-A1 DIHYDRO-OXAZOL DERIVATIVE COMPOUNDS AC IMMUNE SA (CH) 2023-06-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250109126-A1 DIHYDRO-OXAZOL DERIVATIVE COMPOUNDS NLRP3, NLRP1, NOD1 HDAC1 345/4885HDAC6 889/4885CA1 4146/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.